70.10.Z - Head office activities
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
68.20.Z - Rental and management of own or leased real estate
69.20.Z - Accounting, bookkeeping and tax consultancy
70.22.Z - Head office activities and management consultancy
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,8 | 0,3 | 0,8 | 169,8 |
Gross profit (loss) | 0 | 0,3 | 0,5 | 64,7 |
EBITDA | 0,4 | 0,9 | 0,9 | 2,2 |
Short time liabilities | 2,2 | 2,5 | 1,7 | -34,4 |
Other operating costs | 2,2 | 0,3 | 0,3 | -20,1 |
Equity capital | 0,7 | 1 | 1,2 | 18,3 |
Operating profit (EBIT) | 0 | 0,4 | 0,6 | 60,4 |
Assets | 3 | 3,6 | 7,4 | 108 |
Net profit (loss) | 0 | 0,3 | 0,4 | 63,1 |
Cash | 0,2 | 0,1 | 0,1 | 101,7 |
Net income from sale | 8,5 | 12,9 | 12,1 | -6,1 |
Liabilities and provisions for liabilities | 2,3 | 2,6 | 6,2 | 143,4 |
Working assets | 1,3 | 2,7 | 2,9 | 9 |
Other income costs | 0,5 | 0,4 | 0,1 | -82,6 |
Depreciation | 0,3 | 0,6 | 0,4 | -34,6 |
% | % | % | p.p. | |
Profitability of capital | 3,8 | 26,4 | 36,4 | 10 |
Equity capital to total assets | 24,8 | 28,3 | 16,1 | -12,2 |
Gross profit margin | 0,3 | 2,5 | 4,3 | 1,8 |
EBITDA Margin | 4,5 | 7,1 | 7,7 | 0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 92 | 72 | 50 | -22 |
Current financial liquidity indicator | 0.6159488558769226 | 1.0690828561782837 | 1.7769924402236938 | 0,7 |
Net dept to EBITDA | -0.16898785531520844 | -0.04002339765429497 | 4.709909915924072 | 4,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane